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Re: Effect of Age on Risk of
Second Primary Colorectal
Cancer
Patients with a history of colorectal
cancer are at increased risk of second
primary colorectal cancer, with an over-
all excess risk of 1.5-fold to twofold
compared with the general population
(1–4).
On the basis of the large SEER1 da-
tabase, Shureiqi et al. (4) reported that
the standardized incidence ratio (SIR)
of second colorectal primary cancer
decreased with age at diagnosis, from
160 at age 20–29 to 1.1 at age 80 or
older. Since information on this issue
is limited (1,5,6), we exploited data
from the Swiss Cancer Registry of Vaud
for 1974 through 1999. The registry
covers a population of 601 000 inhabit-
ants in 1990; it is tumor-based, and
multiple primary cancers in the same
person are registered separately. Both
passive and active follow-up are re-
corded (2,3).
A total of 6579 subjects with primary
colorectal cancer (excluding anorectal
and anal primary cancers) were regis-
tered and followed for a mean follow-
up of 4.3 years. Overall, 90 second
primary colorectal cancers were ob-
served versus 61.6 expected, corre-
sponding to an SIR of 1.5 (95% confi-
dence interval  1.2 to 1.8). The SIRs,
however, substantially declined with
age at diagnosis, being 38.3 at age
30–39, 7.6 at age 40–49, 2.2 at age 50–
59, and 1.2 at age 60 or older (Table 1).
In contrast, no pattern of risk was
observed with time since diagnosis
of the first primary cancer; the SIR was
1.4 at less than 1 year, 1.3 at 1–4 years,
and 1.7 at 5 years or more since diagno-
sis.
This study, therefore, adds further
quantitative evidence that younger pa-
tients have a strong general predisposi-
tion to develop second primary colorec-
tal cancer. This points to microsatellite
instability and other hereditary defects
in mismatch repair genes (7), including
those observed in hereditary nonpolypo-
sis colon cancer (5).
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RESPONSE
The very informative correspondence
of Dr. Levi and his colleagues provides
further confirmation of the striking in-
verse correlation between age at diagno-
sis of a first colorectal primary cancer
and the risk of a colorectal second pri-
mary tumor (1,2). Consistent studies in
three very large cohorts—ours in the
United States (1), one in Sweden (2),
and now another in Switzerland—
validate the finding that younger age at
the time of colorectal primary cancer di-
agnosis predicts a significantly in-
creased risk for a colorectal second pri-
mary tumor. The Swedish cohort data
(2) showed that the inverse correlation
between age and risk of colorectal sec-
ond primary cancer was more evident in
sporadic colorectal cancer cases than in
familial cases, whose high risk remains
fairly constant across age groups. Fur-
thermore, the majority of the Swedish
familial cases did not have hereditary
nonpolyposis colorectal cancer (2).
These data support the need for in-
creased surveillance for colorectal sec-
ond primary tumors in younger sporadic
cancer patients (notwithstanding the ab-
sence of a family history of colorectal
cancers) (1). These younger patients
also should be encouraged to participate
in colorectal cancer chemoprevention
studies (1). Of course surveillance in fa-
milial cases is necessarily high at any
Table 1. Observed and expected numbers, and standardized incidence ratios (SIRs) with corresponding
95% confidence intervals, of colorectal second primary tumors in colorectal cancer patients, Vaud,
Switzerland, 1974 through 1999
Age, y Observed Expected SIR (95% confidence interval)
30–39 3 0.1 38.3 (7.7 to 111.9)
40–49 7 0.9 7.6 (3.0 to 15.7)
50–59 13 5.9 2.2 (1.2 to 3.8)
60–69 16 15.9 1.0 (0.6 to 1.6)
70–79 40 26.7 1.5 (1.1 to 2.0)
80 11 12.1 0.9 (0.5 to 1.6)
Total 90 61.6 1.5 (1.2 to 1.8)
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age. These findings substantiate our ini-
tial hypothesis that young patients’ in-
creased risk of colorectal second pri-
mary tumors is related to biologic
phenomena that are independent of the
currently known familial cancer syn-
dromes. Clearly, further studies are war-
ranted to identify the molecular basis of
increased second primary tumor risk of
young colorectal cancer patients.
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